Trials of embryonic stem cells to launch in China

David Cyranoski

Nature, 2017, vol. 546, issue 7656, 15-16

Abstract: Studies to treat vision loss and Parkinson’s disease are the first to proceed under new regulations.

Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/546015a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:546:y:2017:i:7656:d:10.1038_546015a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/546015a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().